C32H44N2O10
Neat
616.71
Room Temperature
126883-99-6; Nor Verapamil N-beta-D-Glucuronide; Nor Verapamil N-?-D-Glucuronide; (2S, 3S, 4S, 5R, 6R)-6-[[4-Cyano-4-(3, 4-dimethoxyphenyl)-5-methylhexyl]-[2-(3, 4-dimethoxyphenyl)ethyl]amino]-3, 4, 5-trihydroxyoxane-2-carboxylic acid; beta-D-Glucopyranuronic acid, 1-[[4-cyano-4-(3, 4-dimethoxyphenyl)-5-methylhexyl][2-(3, 4-dimethoxyphenyl)ethyl]amino]-1-deoxy-; Norverapamil N-beta-D-Glucuronide; KZ23L8U26J; 1-[[4-Cyano-4-(3, 4-dimethoxyphenyl)-5-methylhexyl][2-(3, 4-dimethoxyphenyl)ethyl]amino]-1-deoxy-beta-D-glucopyranuronic acid; 6-[[4-cyano-4-(3, 4-dimethoxyphenyl)-5-methylhexyl]-[2-(3, 4-dimethoxyphenyl)ethyl]amino]-3, 4 and 5-trihydroxyoxane-2-carboxylic acid
(2S, 3S, 4S, 5R, 6R)-6-[[4-cyano-4-(3, 4-dimethoxyphenyl)-5-methylhexyl]-[2-(3, 4-dimethoxyphenyl)ethyl]amino]-3, 4 and 5-trihydroxyoxane-2-carboxylic acid
InChI=1S/C32H44N2O10/c1-19(2)32(18-33,21-9-11-23(41-4)25(17-21)43-6)13-7-14-34(15-12-20-8-10-22(40-3)24(16-20)42-5)30-28(37)26(35)27(36)29(44-30)31(38)39/h8-11,16-17,19,26-30,35-37H,7,12-15H2,1-6H3,(H,38,39)/t26-,27-,28+,29-,30+,32?/m0/s1